Invesco S&P 500 Pure Value ETF offers low valuations, but underperforms peers due to high volatility and expenses. Read what ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

A young local startup offering virtual appointments for patients at risk for dementia and cognitive decline is getting ready ...

CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January ...

Salem Health and Regence BlueCross BlueShield of Oregon are returning to the negotiating table after almost 30,000 people ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...

A San Antonio-based healthcare business firm has named a new chief strategy officer. Carenet Health, a company that offers a ...